Jeremy Green, Redmile Group Drop Cyclacel Pharmaceuticals Like It’s Hot

Jeremy Green, Redmile Group: In a passive 13G filing with the SEC just now, the San Francisco-based Redmile Group, managed by Jeremy Green, has closed out its position in Cyclacel...

Keep Reading →